Neurological Oncology

Brain Metastases – Clinical Challenges and Recent Advances

European Neurological Review. 2019;14(1):20–1 DOI: https://doi.org/10.17925/ENR.2019.14.1.20

Brain metastases (BM) are the most frequent among intracranial brain tumours and their incidence is rising as therapeutic advances are improving the survival of patients with advanced cancer. The incidence of BM has been calculated as 9–17% based on various studies, although the true incidence is thought to be higher.1 Patients with BM have a […]

Riccardo Soffietti, EAN 2018 – Advances in personalised therapies for brain tumours (Part 2)

Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in brain tumours. Part 2 of 2. Questions 1. What are the most promising agents targeting […]

Riccardo Soffietti, EAN 2018 – Advances in personalised therapies for brain tumours (Part 1)

Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in brain tumours. Part 1 of 2. Questions 1 What have been the most important recent […]

EAN 2017 – Riccardo Soffietti Interview – Part 3

EAN Programme Committee Member, Prof. Riccardo Soffietti, provides his insights on neuro-oncology coverage at this year’s EAN congress. Part 3 of 3. View Part 1 here. View Part 2 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at the 3rd Congress of the European Academy of Neurology (EAN), Amsterdam, June […]

EAN 2017 – Riccardo Soffietti Interview – Part 2

EAN Programme Committee Member, Prof. Riccardo Soffietti, talks about unmet needs and what he considers will be the most exciting/promising developments in neuro-oncology over the next 2 years. Part 2 of 3. View Part 1 here. View Part 3 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at the 3rd […]

EAN 2017 – Riccardo Soffietti Interview – Part 1

EAN Programme Committee Member, Prof. Riccardo Soffietti, discusses the most significant recent developments in neuro-oncology. Part 1 of 3. View Part 2 here. View Part 3 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at the 3rd Congress of the European Academy of Neurology (EAN), Amsterdam, June 2017.

IDoR 2014 – ECR On Demand: Basic 2 ‘Basic Session on Neuroradiology’ (Brain tumours, M.M. Thurnher)

M.M. Thurnher discusses brain tumour radiology at ECR 2014.

Radiosurgery Versus Radiotherapy Followed by Whole Brain Radiation for Brain Metastases

Kurt Jaeckle, MD, professor of neurology and oncology, Mayo Clinic, discusses radiosurgery versus radiotherapy followed by whole brain radiation for brain metastases.

adjuvant whole brain radiation therapy

Dr Buckner (Mayo Clinic, Rochester, USA) presents, at a press conference at ASCO 2015, a federally funded phase III trial that is providing additional information regarding a long-standing discussion about the impact of adjuvant whole brain radiation therapy (WBRT) on cognitive function.